Charvy Rana, Department of Pathology, AIIMS, New Delhi What is MYCN protein? Cancer often involves the inactivation of tumor-suppressor genes and/or over-activation of oncogenes. The MYCN proto-oncogene is one such example, implicated for its amplified or “oncogenic” status in several neuronal and non-neuronal cancers (those of lung, ovaries, prostate, and more)1. Normally expressed during the […]
Nandini Pharasi, Jaypee Institute of Information Technology What is neuroblastoma? Neuroblastoma is a condition in which malignant cells develop in the adrenal glands, neck, chest, or spinal cords neuroblasts (immature nerve tissue). A gene mutation (change) handed down from parent to kid can develop neuroblastoma. Neuroblastoma is responsible for 8–10% of all malignancies in children […]
Madhavi Bhatia, National Institute of Pharmaceutical Education and Research Guwahati Neuroblastoma is a form of solid tumour found in children. It accounts for about 15% of total cancer-related deaths in children. These tumours develop from a certain type of nerve cells and are found in the abdomen. The current treatment for patients with severe neuroblastoma […]
Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University Our cells divide for growth. Cancer starts when the growth of the cells gets out of control. Any cell can become cancerous at any stage and any age. Cancer development can begin even in fetal cells. What is Neuroblastoma? Neuroblastoma (NB) is a type of cancer that […]
Soumili Chakraborty, Amity University, Kolkata Stem cells undergo asymmetric cell division to give rise to two daughter cells: One daughter cell which is similar to that of the original stem cell, And the second daughter cell differentiates into a non-stem cell. Stem cells are largely studied to understand the underlying mechanisms, by which they contribute to […]
